Terms: = Lung cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
363 results:
1. MELK aggravates lung adenocarcinoma by regulating ezh2 ubiquitination and H3K27me3 histone methylation of LATS2.
Yu H; Xu X; Zhu L; Chen S; He J
J Cell Mol Med; 2024 Apr; 28(8):e18216. PubMed ID: 38652219
[TBL] [Abstract] [Full Text] [Related]
2. PROTAC ezh2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis.
Shi MX; Ding X; Tang L; Cao WJ; Su B; Zhang J
BMC Cancer; 2024 Apr; 24(1):504. PubMed ID: 38644473
[TBL] [Abstract] [Full Text] [Related]
3. Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through ezh2.
Sun H; Zhu R; Guo X; Zhao P; Zhang R; Zhao Z; Zhou H
Pathol Res Pract; 2024 Apr; 256():155271. PubMed ID: 38574630
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
[TBL] [Abstract] [Full Text] [Related]
5. NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.
Xu X; Wang D; Xu W; Li H; Chen N; Li N; Yao Q; Chen W; Zhong J; Mao W
Commun Biol; 2024 Feb; 7(1):206. PubMed ID: 38378967
[TBL] [Abstract] [Full Text] [Related]
6. ezh2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis.
Zhang Q; Shi Y; Liu S; Yang W; Chen H; Guo N; Sun W; Zhao Y; Ren Y; Ren Y; Jia L; Yang J; Yun Y; Chen G; Wang L; Wu C
Cell Rep; 2024 Feb; 43(2):113714. PubMed ID: 38306271
[TBL] [Abstract] [Full Text] [Related]
7. ezh2 Inhibition Promotes Tumor Immunogenicity in lung Squamous Cell Carcinomas.
DuCote TJ; Song X; Naughton KJ; Chen F; Plaugher DR; Childress AR; Gellert AR; Skaggs EM; Qu X; Liu J; Liu J; Li F; Wong KK; Brainson CF
Cancer Res Commun; 2024 Feb; 4(2):388-403. PubMed ID: 38265267
[TBL] [Abstract] [Full Text] [Related]
8. The Interplay Between HIF-1α and ezh2 in lung cancer and Dual-Targeted Drug Therapy.
Wang J; Yang C; Xu H; Fan X; Jia L; Du Y; Liu S; Wang W; Zhang J; Zhang Y; Wang X; Liu Z; Bao J; Li S; Yang J; Wu C; Tang J; Chen G; Wang L
Adv Sci (Weinh); 2024 Feb; 11(7):e2303904. PubMed ID: 38072662
[TBL] [Abstract] [Full Text] [Related]
9. Combined Inhibition of ezh2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
10. Long Non-coding RNA
Endo I; Amatya VJ; Kushitani K; Nakagiri T; Aoe K; Takeshima Y
Anticancer Res; 2023 Dec; 43(12):5367-5376. PubMed ID: 38030172
[TBL] [Abstract] [Full Text] [Related]
11. Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells.
Wu DD; Lau ATY; Xu YM; Reinders-Luinge M; Koncz M; Kiss A; Timens W; Rots MG; Hylkema MN
Epigenetics; 2023 Dec; 18(1):2175522. PubMed ID: 38016026
[TBL] [Abstract] [Full Text] [Related]
12. Metabolic reprogramming driven by ezh2 inhibition depends on cell-matrix interactions.
W-M Fan T; Islam JMM; Higashi RM; Lin P; Brainson CF; Lane AN
J Biol Chem; 2024 Jan; 300(1):105485. PubMed ID: 37992808
[TBL] [Abstract] [Full Text] [Related]
13. Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (ezh2).
Xu X; Chen J; Wang G; Zhang X; Li Q; Zhou X; Guo F; Li M
Bioorg Med Chem Lett; 2024 Jan; 97():129558. PubMed ID: 37956762
[TBL] [Abstract] [Full Text] [Related]
14. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in lung Adenocarcinoma.
Saggese P; Pandey A; Alcaraz M; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Shirihai OS; Weisz A; Dubinett SM; Scafoglio C
Cancer Res; 2024 Jan; 84(2):305-327. PubMed ID: 37934116
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA CALML3-AS1 modulated by m
Zhang H; Wang SQ; Zhu JB; Wang LN; Lin H; Li LF; Cheng YD; Duan CJ; Zhang CF
Cancer Gene Ther; 2023 Dec; 30(12):1649-1662. PubMed ID: 37884580
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
[No Abstract] [Full Text] [Related]
17. SND1, a novel co-activator of HIF1α, promotes tumor initiation in PyMT-induced breast tumor.
Hu L; Zeng Y; Xin L; Yang J
FEBS J; 2023 Dec; 290(24):5759-5772. PubMed ID: 37622244
[TBL] [Abstract] [Full Text] [Related]
18. Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-ezh2 pathway.
Jiang L; Zhou J; Wu Y; Zhou L; Zhang C; Zhu J; Fang Z; Shao Y; Wang W
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101611. PubMed ID: 37619672
[TBL] [Abstract] [Full Text] [Related]
19. The Role of CDK20 Protein in Carcinogenesis.
Chivukula S; Malkhed V
Curr Drug Targets; 2023; 24(10):790-796. PubMed ID: 37469151
[TBL] [Abstract] [Full Text] [Related]
20. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
[Next]
